InvestorsHub Logo

boston745

03/08/19 12:10 PM

#22804 RE: boston745 #22803

For instance LDR initiated a retrospective trial before it's acquisition. Sintx kicked that off 2017 along with several other studies.

SmokerX

03/08/19 12:22 PM

#22806 RE: boston745 #22803

In an attempt to remain unprejudiced and consider the other options I've thrown heavy caution to the idea of Zimmer involvement. Mainly due to it being an unknown. The idea I stumbled upon of AMDA using Omni liners in clinical studies involving the infinia hip then Omni exiting the picture. Then a new hip study involving a Zimmer liner produced in Indiana with the unknown strategic partner wears heavily in my analysis here. The only words of caution in the spirit of critical thinking I can throw out now, based on these given facts is:...well, look at what happened with Omni. nothing came to fruition.

I also question any clinical data revealed in South Africa. Based on the fact it occurred in the medical fields of South Africa. The lack of quality medical care adds a variable too great here to take any data seriously directly related to the facts of the quality of medical care found in South Africa.